MedPath

Ginseng

Generic Name
Ginseng
Drug Type
Biotech
CAS Number
50647-08-0
Unique Ingredient Identifier
CUQ3A77YXI

Overview

Ginseng is promoted as an adaptogen (a product that increases the body's resistance to stress), one which can to a certain extent be supported with reference to its anticarcinogenic and antioxidant properties. Ginseng is also known to contain phytoestrogens.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2015/11/11
Not Applicable
Completed
Chinese PLA General Hospital
2015/03/12
Early Phase 1
Completed
2014/08/07
Phase 2
Completed
Daegu Catholic University Medical Center
2012/10/23
Phase 2
Completed
2012/08/14
Phase 4
Completed
2011/06/17
Phase 1
Active, not recruiting
2009/11/01
Not Applicable
Completed
Frederiksberg University Hospital
2008/10/29
Early Phase 1
Completed
2008/03/10
Phase 2
Completed
2006/11/17
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
HIYA KIOGAN SILVER PILLS
N/A
N/A
N/A
8/23/1999

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.